Survey: Short-stay residents want more help with meds, clinician connections upon discharge
By
Alicia Lasek
Nov 03, 2021
Fully 80% of respondents said they received and understood their discharge instructions. But at least two-thirds would have liked more help with their medication regimen, physician referrals, and other...
National survey tells story of COVID in assisted living
By
Alicia Lasek
Aug 19, 2021
New industry data from the CDC’s National Center for Health Statistics details how COVID-19 affected assisted living communities across the country during the height of the pandemic.
Most COVID-19 antibody treatments given in assisted living, analysts find
By
Alicia Lasek
Feb 22, 2021
Fully 67% of monoclonal antibody treatments have been administered in assisted living communities. Health officials would like to encourage greater use.
Top concern of post-acute patients is staff competence, small study finds
By
Alicia Lasek
Dec 14, 2022
Staff competence and professionalism lend confidence that restored health and independence are in sight, patients told investigators.
Study: Residents received more mental health-related prescriptions during pandemic
By
Alicia Lasek
Nov 10, 2022
Long-stay nursing home residents were more depressed during the pandemic and also treated more often with drugs that work on the central nervous system, according to a study across Michigan facilities.
Improved cardiorespiratory fitness helps lower dementia risk: study
By
Alicia Lasek
Nov 12, 2019
Improving cardiorespiratory fitness over time halves dementia risk in older adults, a unique health survey analysis has found.
Loneliness linked to Parkinson’s disease development, researchers say
By
Kristen Fischer
Oct 03, 2023
A new study has linked loneliness to an increased risk for being diagnosed with Parkinson’s disease. The link was seen across different demographic groups, and it also existed despite risk factors like...
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
McKnight’s Senior Living survey: 75% report PPE shortages in senior living communities
By
Lois A. Bowers
Apr 07, 2020
“We are using homemade masks, as we are allotted one box of 50 masks a month. I have 53 employees,” one respondent said.